These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3926565)

  • 1. Prostaglandin E2 metabolite levels during diabetic ketoacidosis.
    McRae JR; Day RP; Metz SA; Halter JB; Ensinck JW; Robertson RP
    Diabetes; 1985 Aug; 34(8):761-6. PubMed ID: 3926565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects.
    Axelrod L; Shulman GI; Blackshear PJ; Bornstein W; Roussell AM; Aoki TT
    Diabetes; 1986 Sep; 35(9):1004-10. PubMed ID: 3091434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between plasma insulin level, prostaglandin production by adipose tissue, and blood pressure in normal rats and rats with diabetes mellitus and diabetic ketoacidosis.
    Chatzipanteli K; Head C; Megerman J; Axelrod L
    Metabolism; 1996 Jun; 45(6):691-8. PubMed ID: 8637442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
    Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP
    J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
    Newman WP; Brodows RG
    J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
    Linfoot P; Bergstrom C; Ipp E
    Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased insulin binding to erythrocytes in diabetic ketoacidosis: normalization with insulin therapy.
    Yasuda K; Kitabchi AE
    J Clin Endocrinol Metab; 1982 Sep; 55(3):408-12. PubMed ID: 6808004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition.
    Avogaro A; Crepaldi C; Piarulli F; Milan D; Valerio A; Pavan P; Sacerdoti D; Calabrò A; Macdonald I; Crepaldi G; Scognamiglio R; Tiengo A
    Diabetes; 1996 May; 45(5):602-9. PubMed ID: 8621010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon and diabetes. I. The failure of hyperglucagonaemia to influence the response of established diabetic ketoacidosis to therapy.
    Perry-Keene DA; Alford FP; Chisholm DJ; Findlay DM; Larkins RG; Martin FI
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):417-23. PubMed ID: 407039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.
    Diem P; Robertson RP
    Br J Clin Pharmacol; 1991 Nov; 32(5):563-7. PubMed ID: 1954071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 and-2 levels in children with diabetic ketoacidosis.
    Akıncı A; Aydın Ö; Özerol Hİ
    J Clin Res Pediatr Endocrinol; 2009; 1(3):144-50. PubMed ID: 21274399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion and plasma levels of norepinephrine and epinephrine during diabetic ketoacidosis.
    Bolli G; Compagnucci P; Cartechini MG; De Feo P; Santeusanio F; Puxeddu A; Brunetti P
    Acta Diabetol Lat; 1979; 16(2):157-67. PubMed ID: 113975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.
    Axelrod L; Levine L
    Diabetes; 1982 Nov; 31(11):994-1001. PubMed ID: 6816644
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary prostaglandins in hyperglycaemic ketoacidosis of type I diabetes mellitus.
    Miltényi M; Tulassay T; Szabó A; Körner A; Seyberth HW
    Pediatr Nephrol; 1990 Jan; 4(1):44-7. PubMed ID: 2119682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic ketoacidosis: counter-regulatory hormones versus insulin in therapeutic response. Report of a case.
    Schade DS; Kaufman E; Eaton RP
    Rocky Mt Med J; 1977; 74(6):312-5. PubMed ID: 416484
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man.
    Galbo H; Holst JJ; Christensen NJ
    J Appl Physiol; 1975 Jan; 38(1):70-6. PubMed ID: 1110246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.